Objectives/Goals: Cancer cachexia is a wasting condition common in pancreatic cancer, marked by loss of muscle, fat, and bone and driven by inflammation. Immune signals contribute to this damage. This study examines how muscle-resident macrophages may regulate muscle loss in pancreatic cancer cachexia. Methods/Study Population: To identify resident macrophages in cachectic muscle, Lyve1Cre-Rosa26;TdTomato mice were orthotopically transplanted with KPCML1 pancreatic cancer cells. Resident macrophages were analyzed via flow cytometry and immunohistochemistry. For muscle-specific macrophage ablation, lyve1-DTR mice (C57BL/6 background) received tumor cell injections followed by intramuscular diphtheria toxin (DTA) in the TA muscle. Quantitative RT-PCR assessed gene expression from whole muscle lysates and flow-sorted TdTomato+ cells. Results/Anticipated Results: We show that the population of muscle-resident macrophages increased as tumor burden increased. Further findings reveal that the ablation of the resident population of macrophages exacerbates muscle loss, suggesting that muscle-resident macrophages exude a protective phenotype on skeletal myofibers. This was confirmed with increased expression of atrophy biomarkers, MuRF1 and Atrogin-1, in muscles from DTA-injected mice. Additionally, preliminary data revealed an expansion of Toll-like receptor 7 (TLR7) expression in muscle-resident macrophages, suggesting that TLR7 signaling may contribute to their phenotypic regulation in cachexia. Discussion/Significance of Impact: Results suggest muscle-resident macrophages protect against cachexia-induced atrophy via anti-inflammatory activity. Future work will define their signals and targets. Given TLR7 upregulation, we will test if TLR7 signaling regulates their phenotype and contributes to muscle atrophy.
Udeme et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: